BELGRADE (Serbia), December 14 (SeeNews) – More than 100 million euro ($146 million) in sales revenue and assets exceeding 250 million euro in 2008 are two of the requirements that the potential buyers of Serbia's largest drug maker Galenika must meet, the government's Privatisation Agency said on Monday.